Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-26-019891
Filing Date
2026-03-19
Accepted
2026-03-19 17:43:08
Documents
1
Period of Report
2026-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1773956586.html 4  
1 FORM 4 wk-form4_1773956586.xml 4 3503
  Complete submission text file 0001628280-26-019891.txt   5289
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PACIRA BIOSCIENCES, INC. 5401 WEST KENNEDY BOULEVARD, SUITE 890 TAMPA FL 33609
Business Address
SLONIN JONATHAN (Reporting) CIK: 0001875723 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 26775382